These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of vigabatrin on cognitive performances and behaviour in patients with drug-resistant epilepsy. Provinciali L, Bartolini M, Mari F, Del Pesce M, Ceravolo MG. Acta Neurol Scand; 1996 Jul; 94(1):12-8. PubMed ID: 8874587 [Abstract] [Full Text] [Related]
4. Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients? McKee PJ, Blacklaw J, Friel E, Thompson GG, Gillham RA, Brodie MJ. Epilepsia; 1993 Jul; 34(5):937-43. PubMed ID: 8404750 [Abstract] [Full Text] [Related]
12. No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. PMS Study Multicenter Group. Mauguière F, Chauvel P, Dewailly J, Dousse N. Epilepsia; 1997 Mar; 38(3):301-8. PubMed ID: 9070592 [Abstract] [Full Text] [Related]
13. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism. Spanaki MV, Siegel H, Kopylev L, Fazilat S, Dean A, Liow K, Ben-Menachem E, Gaillard WD, Theodore WH. Neurology; 1999 Oct 22; 53(7):1518-22. PubMed ID: 10534261 [Abstract] [Full Text] [Related]
18. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs. Armijo JA, Cuadrado A, Bravo J, Arteaga R. Ther Drug Monit; 1997 Oct 22; 19(5):491-8. PubMed ID: 9357089 [Abstract] [Full Text] [Related]